all

Characteristic N = 17,6651
age 66 (57, 74)
Gender_Legal_Sex
    Female 8,282 (47%)
    Male 9,383 (53%)
male
    0 8,282 (47%)
    1 9,383 (53%)
Race
    Asian 610 (3.5%)
    Black 540 (3.1%)
    Other/Unknown 809 (4.6%)
    White 15,706 (89%)
Ethnic_Group
    Hispanic 359 (2.0%)
    Non_hispanic 16,254 (92%)
    Other 1,052 (6.0%)
ckd_incidence
    0 16,946 (96%)
    1 719 (4.1%)
ckd_progression
    0 16,164 (92%)
    1 1,501 (8.5%)
eskd_composite
    0 17,560 (99%)
    1 105 (0.6%)
ckd_composite
    0 15,402 (87%)
    1 2,263 (13%)
survival_1year
    0 9,391 (53%)
    1 8,274 (47%)
survival_2year
    0 14,286 (81%)
    1 3,379 (19%)
survival_3year
    0 15,421 (87%)
    1 2,244 (13%)
survival_4year
    0 16,422 (93%)
    1 1,243 (7.0%)
survival_5year
    0 16,864 (95%)
    1 801 (4.5%)
survival_6year
    0 17,054 (97%)
    1 611 (3.5%)
survival_7year
    0 17,230 (98%)
    1 435 (2.5%)
survival_8year
    0 17,379 (98%)
    1 286 (1.6%)
survival_9year
    0 17,482 (99%)
    1 183 (1.0%)
survival_10year
    0 17,529 (99%)
    1 136 (0.8%)
death_1year
    0 9,391 (53%)
    1 8,274 (47%)
death_2year
    0 6,012 (34%)
    1 11,653 (66%)
death_3year
    0 3,768 (21%)
    1 13,897 (79%)
death_4year
    0 2,525 (14%)
    1 15,140 (86%)
death_5year
    0 1,724 (9.8%)
    1 15,941 (90%)
death_6year
    0 1,113 (6.3%)
    1 16,552 (94%)
death_7year
    0 678 (3.8%)
    1 16,987 (96%)
death_8year
    0 392 (2.2%)
    1 17,273 (98%)
death_9year
    0 209 (1.2%)
    1 17,456 (99%)
death_10year
    0 73 (0.4%)
    1 17,592 (100%)
dm
    0 15,031 (85%)
    1 2,634 (15%)
htn
    0 7,002 (40%)
    1 10,663 (60%)
cad
    0 13,541 (77%)
    1 4,124 (23%)
esrd_kt
    0 17,665 (100%)
ace_arb
    0 10,244 (58%)
    1 7,421 (42%)
diu
    0 8,274 (47%)
    1 9,391 (53%)
ppi
    0 5,006 (28%)
    1 12,659 (72%)
steroids
    0 4,527 (26%)
    1 13,138 (74%)
smoking
    0 8,749 (50%)
    1 8,916 (50%)
pre_CRE_180days 0.85 (0.70, 1.03)
pre_HGB_180days 12.30 (10.80, 13.50)
    Unknown 14
pre_ALB_180days 4.00 (3.70, 4.30)
    Unknown 67
eGFR_cre 89 (71, 100)
1 Median (Q1, Q3); n (%)

1year

Characteristic N = 8,2741
age 67 (58, 75)
Gender_Legal_Sex
    Female 3,803 (46%)
    Male 4,471 (54%)
male
    0 3,803 (46%)
    1 4,471 (54%)
Race
    Asian 324 (3.9%)
    Black 276 (3.3%)
    Other/Unknown 413 (5.0%)
    White 7,261 (88%)
Ethnic_Group
    Hispanic 180 (2.2%)
    Non_hispanic 7,605 (92%)
    Other 489 (5.9%)
ckd_incidence_1year
    0 8,247 (100%)
    1 27 (0.3%)
ckd_progression_1year
    0 7,898 (95%)
    1 376 (4.5%)
eskd_composite_1year
    0 8,246 (100%)
    1 28 (0.3%)
ckd_composite_1year
    0 7,854 (95%)
    1 420 (5.1%)
dm
    0 6,929 (84%)
    1 1,345 (16%)
htn
    0 3,124 (38%)
    1 5,150 (62%)
cad
    0 6,100 (74%)
    1 2,174 (26%)
ace_arb
    0 5,051 (61%)
    1 3,223 (39%)
diu
    0 3,832 (46%)
    1 4,442 (54%)
ppi
    0 2,399 (29%)
    1 5,875 (71%)
steroids
    0 2,026 (24%)
    1 6,248 (76%)
smoking
    0 4,156 (50%)
    1 4,118 (50%)
pre_CRE_180days 0.83 (0.68, 1.03)
pre_HGB_180days 11.70 (10.20, 13.00)
    Unknown 6
pre_ALB_180days 3.80 (3.40, 4.20)
    Unknown 24
eGFR_cre 90 (70, 101)
ckd_stage
    1 4,086 (49%)
    2 2,842 (34%)
    3 1,237 (15%)
    4 100 (1.2%)
    5 9 (0.1%)
1 Median (Q1, Q3); n (%)

2year

Characteristic N = 3,3791
age 66 (57, 74)
Gender_Legal_Sex
    Female 1,664 (49%)
    Male 1,715 (51%)
male
    0 1,664 (49%)
    1 1,715 (51%)
Race
    Asian 124 (3.7%)
    Black 116 (3.4%)
    Other/Unknown 156 (4.6%)
    White 2,983 (88%)
Ethnic_Group
    Hispanic 82 (2.4%)
    Non_hispanic 3,111 (92%)
    Other 186 (5.5%)
ckd_incidence_2year
    0 3,251 (96%)
    1 128 (3.8%)
ckd_progression_2year
    0 2,981 (88%)
    1 398 (12%)
eskd_composite_2year
    0 3,359 (99%)
    1 20 (0.6%)
ckd_composite_2year
    0 2,845 (84%)
    1 534 (16%)
dm
    0 2,868 (85%)
    1 511 (15%)
htn
    0 1,358 (40%)
    1 2,021 (60%)
cad
    0 2,634 (78%)
    1 745 (22%)
ace_arb
    0 1,912 (57%)
    1 1,467 (43%)
diu
    0 1,534 (45%)
    1 1,845 (55%)
ppi
    0 937 (28%)
    1 2,442 (72%)
steroids
    0 864 (26%)
    1 2,515 (74%)
smoking
    0 1,647 (49%)
    1 1,732 (51%)
pre_CRE_180days 0.85 (0.70, 1.03)
pre_HGB_180days 12.40 (11.10, 13.60)
    Unknown 2
pre_ALB_180days 4.10 (3.80, 4.40)
    Unknown 17
eGFR_cre 89 (70, 100)
ckd_stage
    1 1,624 (48%)
    2 1,263 (37%)
    3 458 (14%)
    4 34 (1.0%)
    5 0 (0%)
1 Median (Q1, Q3); n (%)

3year

Characteristic N = 2,2441
age 66 (57, 74)
Gender_Legal_Sex
    Female 1,088 (48%)
    Male 1,156 (52%)
male
    0 1,088 (48%)
    1 1,156 (52%)
Race
    Asian 77 (3.4%)
    Black 70 (3.1%)
    Other/Unknown 95 (4.2%)
    White 2,002 (89%)
Ethnic_Group
    Hispanic 42 (1.9%)
    Non_hispanic 2,058 (92%)
    Other 144 (6.4%)
ckd_incidence_3year
    0 2,090 (93%)
    1 154 (6.9%)
ckd_progression_3year
    0 1,947 (87%)
    1 297 (13%)
eskd_composite_3year
    0 2,225 (99%)
    1 19 (0.8%)
ckd_composite_3year
    0 1,788 (80%)
    1 456 (20%)
dm
    0 1,920 (86%)
    1 324 (14%)
htn
    0 950 (42%)
    1 1,294 (58%)
cad
    0 1,762 (79%)
    1 482 (21%)
ace_arb
    0 1,270 (57%)
    1 974 (43%)
diu
    0 1,110 (49%)
    1 1,134 (51%)
ppi
    0 645 (29%)
    1 1,599 (71%)
steroids
    0 608 (27%)
    1 1,636 (73%)
smoking
    0 1,131 (50%)
    1 1,113 (50%)
pre_CRE_180days 0.85 (0.72, 1.04)
pre_HGB_180days 12.60 (11.40, 13.90)
    Unknown 1
pre_ALB_180days 4.20 (3.90, 4.40)
    Unknown 10
eGFR_cre 87 (71, 99)
ckd_stage
    1 1,006 (45%)
    2 909 (41%)
    3 310 (14%)
    4 18 (0.8%)
    5 1 (<0.1%)
1 Median (Q1, Q3); n (%)

4year

Characteristic N = 1,2431
age 66 (57, 73)
Gender_Legal_Sex
    Female 574 (46%)
    Male 669 (54%)
male
    0 574 (46%)
    1 669 (54%)
Race
    Asian 33 (2.7%)
    Black 35 (2.8%)
    Other/Unknown 55 (4.4%)
    White 1,120 (90%)
Ethnic_Group
    Hispanic 20 (1.6%)
    Non_hispanic 1,157 (93%)
    Other 66 (5.3%)
ckd_incidence_4year
    0 1,137 (91%)
    1 106 (8.5%)
ckd_progression_4year
    0 1,087 (87%)
    1 156 (13%)
eskd_composite_4year
    0 1,235 (99%)
    1 8 (0.6%)
ckd_composite_4year
    0 979 (79%)
    1 264 (21%)
dm
    0 1,075 (86%)
    1 168 (14%)
htn
    0 532 (43%)
    1 711 (57%)
cad
    0 1,007 (81%)
    1 236 (19%)
ace_arb
    0 671 (54%)
    1 572 (46%)
diu
    0 583 (47%)
    1 660 (53%)
ppi
    0 384 (31%)
    1 859 (69%)
steroids
    0 319 (26%)
    1 924 (74%)
smoking
    0 601 (48%)
    1 642 (52%)
pre_CRE_180days 0.88 (0.73, 1.05)
pre_HGB_180days 12.80 (11.50, 14.00)
    Unknown 4
pre_ALB_180days 4.20 (3.90, 4.40)
    Unknown 8
eGFR_cre 86 (69, 98)
ckd_stage
    1 522 (42%)
    2 543 (44%)
    3 171 (14%)
    4 7 (0.6%)
    5 0 (0%)
1 Median (Q1, Q3); n (%)

5year

Characteristic N = 8011
age 66 (57, 73)
Gender_Legal_Sex
    Female 367 (46%)
    Male 434 (54%)
male
    0 367 (46%)
    1 434 (54%)
Race
    Asian 15 (1.9%)
    Black 18 (2.2%)
    Other/Unknown 32 (4.0%)
    White 736 (92%)
Ethnic_Group
    Hispanic 10 (1.2%)
    Non_hispanic 742 (93%)
    Other 49 (6.1%)
ckd_incidence_5year
    0 718 (90%)
    1 83 (10%)
ckd_progression_5year
    0 700 (87%)
    1 101 (13%)
eskd_composite_5year
    0 793 (99%)
    1 8 (1.0%)
ckd_composite_5year
    0 616 (77%)
    1 185 (23%)
dm
    0 695 (87%)
    1 106 (13%)
htn
    0 324 (40%)
    1 477 (60%)
cad
    0 626 (78%)
    1 175 (22%)
ace_arb
    0 414 (52%)
    1 387 (48%)
diu
    0 392 (49%)
    1 409 (51%)
ppi
    0 214 (27%)
    1 587 (73%)
steroids
    0 215 (27%)
    1 586 (73%)
smoking
    0 372 (46%)
    1 429 (54%)
pre_CRE_180days 0.87 (0.73, 1.06)
pre_HGB_180days 12.90 (11.40, 14.00)
pre_ALB_180days 4.20 (3.90, 4.40)
    Unknown 2
eGFR_cre 87 (70, 98)
ckd_stage
    1 348 (43%)
    2 343 (43%)
    3 107 (13%)
    4 2 (0.2%)
    5 1 (0.1%)
1 Median (Q1, Q3); n (%)

6year

Characteristic N = 6111
age 64 (55, 72)
Gender_Legal_Sex
    Female 268 (44%)
    Male 343 (56%)
male
    0 268 (44%)
    1 343 (56%)
Race
    Asian 19 (3.1%)
    Black 2 (0.3%)
    Other/Unknown 20 (3.3%)
    White 570 (93%)
Ethnic_Group
    Hispanic 11 (1.8%)
    Non_hispanic 567 (93%)
    Other 33 (5.4%)
ckd_incidence_6year
    0 529 (87%)
    1 82 (13%)
ckd_progression_6year
    0 548 (90%)
    1 63 (10%)
eskd_composite_6year
    0 606 (99%)
    1 5 (0.8%)
ckd_composite_6year
    0 463 (76%)
    1 148 (24%)
dm
    0 547 (90%)
    1 64 (10%)
htn
    0 262 (43%)
    1 349 (57%)
cad
    0 490 (80%)
    1 121 (20%)
ace_arb
    0 323 (53%)
    1 288 (47%)
diu
    0 276 (45%)
    1 335 (55%)
ppi
    0 175 (29%)
    1 436 (71%)
steroids
    0 178 (29%)
    1 433 (71%)
smoking
    0 297 (49%)
    1 314 (51%)
pre_CRE_180days 0.87 (0.73, 1.03)
pre_HGB_180days 13.00 (11.80, 14.20)
    Unknown 1
pre_ALB_180days 4.20 (3.90, 4.40)
    Unknown 3
eGFR_cre 88 (73, 99)
ckd_stage
    1 288 (47%)
    2 251 (41%)
    3 69 (11%)
    4 3 (0.5%)
    5 0 (0%)
1 Median (Q1, Q3); n (%)

7year

Characteristic N = 4351
age 63 (54, 70)
Gender_Legal_Sex
    Female 211 (49%)
    Male 224 (51%)
male
    0 211 (49%)
    1 224 (51%)
Race
    Asian 9 (2.1%)
    Black 8 (1.8%)
    Other/Unknown 14 (3.2%)
    White 404 (93%)
Ethnic_Group
    Hispanic 4 (0.9%)
    Non_hispanic 399 (92%)
    Other 32 (7.4%)
ckd_incidence_7year
    0 392 (90%)
    1 43 (9.9%)
ckd_progression_7year
    0 391 (90%)
    1 44 (10%)
eskd_composite_7year
    0 430 (99%)
    1 5 (1.1%)
ckd_composite_7year
    0 344 (79%)
    1 91 (21%)
dm
    0 396 (91%)
    1 39 (9.0%)
htn
    0 187 (43%)
    1 248 (57%)
cad
    0 349 (80%)
    1 86 (20%)
ace_arb
    0 238 (55%)
    1 197 (45%)
diu
    0 219 (50%)
    1 216 (50%)
ppi
    0 110 (25%)
    1 325 (75%)
steroids
    0 117 (27%)
    1 318 (73%)
smoking
    0 210 (48%)
    1 225 (52%)
pre_CRE_180days 0.86 (0.71, 1.01)
pre_HGB_180days 13.40 (12.20, 14.30)
pre_ALB_180days 4.10 (3.90, 4.40)
eGFR_cre 89 (74, 100)
ckd_stage
    1 213 (49%)
    2 171 (39%)
    3 50 (11%)
    4 1 (0.2%)
    5 0 (0%)
1 Median (Q1, Q3); n (%)

8year

Characteristic N = 2861
age 60 (53, 69)
Gender_Legal_Sex
    Female 144 (50%)
    Male 142 (50%)
male
    0 144 (50%)
    1 142 (50%)
Race
    Asian 4 (1.4%)
    Black 8 (2.8%)
    Other/Unknown 16 (5.6%)
    White 258 (90%)
Ethnic_Group
    Hispanic 4 (1.4%)
    Non_hispanic 265 (93%)
    Other 17 (5.9%)
ckd_incidence_8year
    0 253 (88%)
    1 33 (12%)
ckd_progression_8year
    0 255 (89%)
    1 31 (11%)
eskd_composite_8year
    0 280 (98%)
    1 6 (2.1%)
ckd_composite_8year
    0 221 (77%)
    1 65 (23%)
dm
    0 249 (87%)
    1 37 (13%)
htn
    0 112 (39%)
    1 174 (61%)
cad
    0 239 (84%)
    1 47 (16%)
ace_arb
    0 154 (54%)
    1 132 (46%)
diu
    0 135 (47%)
    1 151 (53%)
ppi
    0 58 (20%)
    1 228 (80%)
steroids
    0 61 (21%)
    1 225 (79%)
smoking
    0 127 (44%)
    1 159 (56%)
pre_CRE_180days 0.86 (0.71, 1.05)
pre_HGB_180days 13.20 (12.10, 14.00)
pre_ALB_180days 4.20 (3.90, 4.40)
    Unknown 1
eGFR_cre 91 (71, 102)
ckd_stage
    1 147 (51%)
    2 107 (37%)
    3 30 (10%)
    4 2 (0.7%)
    5 0 (0%)
1 Median (Q1, Q3); n (%)

9year

Characteristic N = 1831
age 62 (52, 69)
Gender_Legal_Sex
    Female 71 (39%)
    Male 112 (61%)
male
    0 71 (39%)
    1 112 (61%)
Race
    Asian 3 (1.6%)
    Black 5 (2.7%)
    Other/Unknown 5 (2.7%)
    White 170 (93%)
Ethnic_Group
    Hispanic 5 (2.7%)
    Non_hispanic 159 (87%)
    Other 19 (10%)
ckd_incidence_9year
    0 149 (81%)
    1 34 (19%)
ckd_progression_9year
    0 166 (91%)
    1 17 (9.3%)
eskd_composite_9year
    0 180 (98%)
    1 3 (1.6%)
ckd_composite_9year
    0 131 (72%)
    1 52 (28%)
dm
    0 161 (88%)
    1 22 (12%)
htn
    0 78 (43%)
    1 105 (57%)
cad
    0 146 (80%)
    1 37 (20%)
ace_arb
    0 91 (50%)
    1 92 (50%)
diu
    0 88 (48%)
    1 95 (52%)
ppi
    0 40 (22%)
    1 143 (78%)
steroids
    0 49 (27%)
    1 134 (73%)
smoking
    0 94 (51%)
    1 89 (49%)
pre_CRE_180days 0.86 (0.74, 1.03)
pre_HGB_180days 12.90 (11.90, 14.10)
pre_ALB_180days 4.10 (3.90, 4.40)
    Unknown 2
eGFR_cre 91 (76, 101)
ckd_stage
    1 102 (56%)
    2 63 (34%)
    3 17 (9.3%)
    4 1 (0.5%)
    5 0 (0%)
1 Median (Q1, Q3); n (%)

10year

Characteristic N = 1831
age 62 (52, 69)
Gender_Legal_Sex
    Female 71 (39%)
    Male 112 (61%)
male
    0 71 (39%)
    1 112 (61%)
Race
    Asian 3 (1.6%)
    Black 5 (2.7%)
    Other/Unknown 5 (2.7%)
    White 170 (93%)
Ethnic_Group
    Hispanic 5 (2.7%)
    Non_hispanic 159 (87%)
    Other 19 (10%)
ckd_incidence_9year
    0 149 (81%)
    1 34 (19%)
ckd_progression_9year
    0 166 (91%)
    1 17 (9.3%)
eskd_composite_9year
    0 180 (98%)
    1 3 (1.6%)
ckd_composite_9year
    0 131 (72%)
    1 52 (28%)
dm
    0 161 (88%)
    1 22 (12%)
htn
    0 78 (43%)
    1 105 (57%)
cad
    0 146 (80%)
    1 37 (20%)
ace_arb
    0 91 (50%)
    1 92 (50%)
diu
    0 88 (48%)
    1 95 (52%)
ppi
    0 40 (22%)
    1 143 (78%)
steroids
    0 49 (27%)
    1 134 (73%)
smoking
    0 94 (51%)
    1 89 (49%)
pre_CRE_180days 0.86 (0.74, 1.03)
pre_HGB_180days 12.90 (11.90, 14.10)
pre_ALB_180days 4.10 (3.90, 4.40)
    Unknown 2
eGFR_cre 91 (76, 101)
ckd_stage
    1 102 (56%)
    2 63 (34%)
    3 17 (9.3%)
    4 1 (0.5%)
    5 0 (0%)
1 Median (Q1, Q3); n (%)